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Abstract
IMPORTANCE There is an urgent need to assess neurodevelopment in Zika virus (ZIKV)–exposed infants.
OBJECTIVES To perform general movement assessment (GMA) at 9 to 20 weeks’ postterm age and
to evaluate whether the findings are associated with neurodevelopmental outcomes at age 12
months in infants prenatally exposed to acute maternal illness with rash in Brazil during the ZIKV
outbreak and in age-matched controls.
DESIGN, SETTING, AND PARTICIPANTS In this cohort study, infants prenatally exposed to acute
maternal illness with rash were recruited at medical institutions in Rio de Janeiro and Belo Horizonte,
Brazil, from February 1, 2016, to April 30, 2017, while infants without any exposure to maternal illness
originated from the Graz University Audiovisual Research Database for the Interdisciplinary Analysis
of Neurodevelopment. Participants were 444 infants, including 76 infants without congenital
microcephaly, 35 infants with microcephaly, and 333 neurotypical children matched for sex,
gestational age at birth, and age at GMA.
MAIN OUTCOMES AND MEASURES General movement assessment performed at 9 to 20 weeks’
postterm age, with negative predictive value, positive predictive value, sensitivity, and specificity
generated, as well as clinical, neurologic, and developmental status (Bayley Scales of Infant and
Toddler Development, Third Edition [Bayley-III] scores) at age 12 months. Motor Optimality Scores
were generated based on the overall quality of the motor repertoire. Adverse outcomes were
defined as a Bayley-III score less than 2 SD in at least 1 domain, a score less than 1 SD in at least 2
domains, and/or atypical neurologic findings.
RESULTS A total of 444 infants were enrolled, including 111 children prenatally exposed to a
maternal illness with rash and 333 children without any prenatal exposure to maternal illness (57.7%
male and mean [SD] age, 14 [2] weeks for both groups); 82.1% (46 of 56) of ZIKV-exposed infants
without congenital microcephaly were healthy at age 12 months. Forty-four of 46 infants were
correctly identified by GMA at 3 months, with a negative predictive value of 94% (95% CI,
85%-97%). Seven of 10 ZIKV-exposed children without microcephaly with adverse
neurodevelopmental outcomes were identified by GMA. The GMA positive predictive value was 78%
(95% CI, 46%-94%), sensitivity was 70% (95% CI, 35%-93%), specificity was 96% (95% CI,
85%-99%), and accuracy was 91% (95% CI, 80%-97%). Children with microcephaly had bilateral
spastic cerebral palsy; none had normal movements. The Motor Optimality Score differentiated
outcomes: the median Motor Optimality Score was 23 (interquartile range [IQR], 21-26) in children
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Abstract (continued)
with normal development, 12 (IQR, 8-19) in children with adverse outcomes, and 5 (IQR, 5-6) in
children with microcephaly, a significant difference (P = .001).
CONCLUSIONS AND RELEVANCE This study suggests that although a large proportion of ZIKV-
exposed infants without microcephaly develop normally, many do not. The GMA should be
incorporated into routine infant assessments to enable early entry into targeted treatment programs.
JAMA Network Open. 2019;2(1):e187235. doi:10.1001/jamanetworkopen.2018.7235
Introduction
Symptomatic Zika virus (ZIKV) infection of pregnant women is characterized by an acute illness with
fatigue and malaise, arthralgia, conjunctivitis, and most characteristically a pruritic rash.1-4 Similar
symptoms also occur in other mosquito-borne flavivirus infections, such as dengue or chikungunya.
Differential diagnosis requires real-time reverse transcriptase–polymerase chain reaction (RT-PCR)
assays performed on blood, urine, or both during the acute period of illness.5 Serologic testing often
poses problems in areas where Zika and dengue viruses cocirculate due to serologic cross-
reactivity.
After the 2015-2016 ZIKV epidemic in Brazil, the Americas, and beyond, as well as recognition
of the associated neurologic findings in infants with vertical exposure to ZIKV,3,6,7 we were
confronted with the urgent need to answer multiple questions. What proportion of infants have
normal neurologic outcomes after prenatal exposure to maternal Zika infection? At what age can
families be reassured that their child will develop normally? Is it possible to anticipate neurologic
sequelae? When should early interventions start?
The application of a reliable and valid diagnostic tool, such as the general movement
assessment (GMA), to functionally assess the integrity of the developing nervous system may yield
particular insights.8,9 The GMA, a gestalt-based observational method to classify early motor
functions in the first months of life, has shown merits for the prediction of both normal
neurodevelopment and adverse outcomes.8,10,11
In this study, we aimed to assess the integrity of the developing nervous system by analyzing
the neuromotor repertoire of infants prenatally exposed to ZIKV. In a large multicenter approach,
GMA was part of the follow-up protocol of the Zika Rio de Janeiro cohort,2 which included infants
prenatally exposed to acute maternal illness with rash and/or ZIKV infection. In addition, GMA was
used to assess a select sample of infants with microcephaly after congenital ZIKV infection and a
large group of age- and sex-matched neurotypical control infants for comparison. Specifically, we
aimed (1) to describe global general movement patterns at 3 to 5 months’ postterm age (ie, fidgety
movements) together with the age-specific concurrent motor repertoire (ie, detailed GMA) and (2)
to relate the integrity of neural functions (through global and detailed GMA) to the time of prenatal
exposure to maternal illness, preterm birth, and positive vs negative results on RT-PCR assays (for
ZIKV infection), as well as relating to the head circumference z score in the case of microcephaly (ie,
microcephaly severity) and to outcomes at age 12 months in the case of ZIKV-positive infants (ie, how
many infants prenatally exposed to ZIKV were neurotypical developers and how many had adverse
findings by age 1 year).
Methods
The study was approved by institutional review boards at the Medical University of Graz (Graz,
Austria), the SARAH network of rehabilitation hospitals (Belo Horizonte, Brazil), Fundação Oswaldo
Cruz (Fiocruz) (Rio de Janeiro, Brazil), the University of São Paulo (São Paulo, Brazil), the University of
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Chicago (Chicago, Illinois), and the University of California (Los Angeles). Written informed consent
for recording, storage, and scientific use of audiovisual data was obtained for all infants.
Study Design
This was an observational cohort study composed of 2 groups of children. The study followed the
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
The first group included children exposed in utero to a maternal exanthematous illness during the ZIKV
epidemic in Brazil; the second group included infants without any perinatal ZIKV exposure from the
Graz University Audiovisual Research Database for the Interdisciplinary Analysis of Neurodevelopment
(GUARDIAN).
Setting
The study was conducted at the SARAH network of rehabilitation hospitals in Belo Horizonte and at
Fiocruz in Rio de Janeiro (both in Brazil) and at the Medical University of Graz in Graz, Austria. Infant
recruitment for ZIKV-exposed children was from February 1, 2016, and April 30, 2017. Infant
follow-up for Bayley Scales of Infant and Toddler Development, Third Edition12 (Bayley-III) testing
was performed until June 2018. Infants without ZIKV exposure were selected from the GUARDIAN
database.
Participants
A total of 444 infants were enrolled between February 1, 2016, and April 30, 2017, including 111
children prenatally exposed to an acute maternal illness with rash during the ZIKV epidemic and 333
neurotypical control children (57.7% male and mean [SD] age, 14 [2] weeks for both groups).
Seventy-eight infants born to mothers with an acute illness with rash during pregnancy originated
from the Rio de Janeiro Zika cohort2 (Fiocruz, Rio de Janeiro, Brazil). Two infants had microcephaly at
birth; prenatal and perinatal data are published elsewhere.2 An additional 33 infants with
microcephaly due to congenital Zika syndrome followed up at the SARAH network of rehabilitation
hospitals in Belo Horizonte, Brazil, were included. Microcephaly was defined as previously
described.2 All 35 infants with microcephaly were diagnosed as having disproportionate
microcephaly and had clinical and imaging findings consistent with congenital Zika syndrome. Fifty-
eight of 78 mothers (74.4%) in Rio de Janeiro tested positive for ZIKV by RT-PCR of blood, urine, or
both at the time of rash. The remaining 20 infants were born to mothers with an acute
exanthematous illness during pregnancy who tested negative by RT-PCR for ZIKV infection at the
time of rash (Figure).
Variables
For infant categorization, infants were enrolled in the exposure category if mothers had an acute
illness with rash during pregnancy at the time of the ZIKV outbreak in Brazil. All 111 infants in the
exposure category were matched for sex, gestational age at birth, and age at GMA to 3 infants
without perinatal ZIKV exposure (n = 333) and with normal Bayley-III scores (Figure). Infants
unexposed to ZIKV were randomly selected from the GUARDIAN database, which comprises more
than 2000 standardized GMA data sets collected worldwide. Because general movements are
endogenously generated motor patterns not influenced by culture or race/ethnicity,9 these variables
were disregarded as matching criteria.
General Movement Assessment
Details about GMA8,9 are provided in the eAppendix in the Supplement. At 9 to 20 weeks’ postterm
age, infants were videotaped for 4 to 5 minutes of active wakefulness lying in supine position and
without manipulation. All children whose mothers tested positive for ZIKV without microcephaly
(n = 56) were reassessed at age 12 months. We chose Bayley-III12 for developmental testing because
it is validated cross-culturally for Brazil.13 A score below 70 (ie, <2 SD) in the cognitive, language, or
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motor domain indicates severe developmental delay.12 We considered an adverse outcome as (1) a
Bayley-III score less than 2 SD in at least 1 developmental domain, (2) a moderate developmental
delay (<1 SD) in at least 2 domains (Bayley-III score <85), and/or (3) atypical neurologic findings.
Infants of ZIKV-negative mothers (n = 20) did not have Bayley-III performed because they were
referred elsewhere for pediatric follow-up once ZIKV infection was excluded. Children with
microcephaly (n = 35) could not complete testing due to inability to follow directions. All control
infants (n = 333) scored within normal range for all developmental domains (Figure).
Data Sources and Measurement
The GMA and Bayley-III assessments for infants with exposure to maternal illness during pregnancy
were conducted prospectively by study personnel in Brazil (F.U., C.Y.P.A., R.H.H., and F.F.G.), with the
results recorded in case report forms. Infants without ZIKV exposure were selected from the
GUARDIAN database in Graz. The same assessments were performed in both groups of children;
study personnel in Brazil were trained by Graz investigators (C.E. and P.B.M.) to perform required
study assessments previously obtained for database children.
Bias
Study personnel performing GMA and interpreting the results (C.E., F.U., C.Y.P.A., C.P., R.H.H., F.F.G.,
and P.B.M.) were masked as to which infants had a confirmed diagnosis of antenatal ZIKV exposure
vs maternal rash during pregnancy. Study personnel could not be masked to microcephaly; however,
this was taken into consideration. All GMA videotapes were analyzed by at least 2 certified GMA
experts (including C.I. and P.B.M.), with interscorer agreements of Cohen or Fleiss κ statistics ranging
from 0.88 to 0.96 and intraclass correlation coefficients exceeding 0.90. The GMA experts were
masked to the perinatal history, RT-PCR results, and final outcomes of participants. Staff members
Figure. Prospective Cohort of Infants Prenatally Exposed to Acute Maternal Illness With Rash and Neurotypical Controls
444 Infants were enrolled
111 Infants prenatally exposed
to acute maternal illness
with rash
























20 Negative for ZIKV
by RT-PCR assay
333 Neurotypical controls
100% (34 of 34)
Adverse outcome
0% (0 of 333)
Adverse outcome
Adverse outcomes included neurologic deficits and/or abnormal Bayley Scales of Infant
and Toddler Development, Third Edition (Bayley-III) results as defined in the text.
Positive and negative for Zika virus by reverse transcriptase–polymerase chain reaction
assay plus infants referred for congenital Zika syndrome. GMFCS indicates Gross Motor
Function Classification System.
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conducting developmental testing of the ZIKV cohort (C.E., F.U., and M.E.M.) were aware that
toddlers were born to ZIKV-infected mothers, but had no information about GMA results. Children
with microcephaly did not undergo developmental testing because they all had spastic cerebral palsy
Gross Motor Function Classification System level IV, which renders them untestable. Masked
assessment was not possible in children with microcephaly.
Study Size
A total of 111 infants were enrolled in the maternal illness exposure cohort; this was the number of
infants who came to clinic visits at the participating sites during the age window period necessary for
GMA evaluations and whose parents or guardians provided written informed consent. All exposed
infants were matched to 3 infants in the database without perinatal ZIKV exposure and with normal
Bayley-III scores (n = 333), for a total sample size of 444 infants.
Quantitative Variables
Quantitative variables were assessed. These included the Motor Optimality Score (MOS) and number
of movement and postural patterns, apart from the core data, such as age, birthweight, and head
circumference. The GMA data and Bayley-III scores were analyzed as categorical variables.
Statistical Analysis
Using Pearson χ2 test or Fisher exact test (2 sided), we compared categorical data (clinical history and
GMA) of infants who were prenatally exposed to acute maternal illness with rash (infants of mothers
who were ZIKV RT-PCR positive or ZIKV RT-PCR negative and infants with microcephaly after
congenital ZIKV infection) vs age-matched controls. To determine whether 2 independent samples
(eg, ZIKV positive vs ZIKV negative, infants with congenital ZIKV vs controls, or normal vs adverse
outcome) had the same distribution of their continuous variables (eg, MOS9), we applied the Mann-
Whitney test. Two-sided P  .05 was considered statistically significant. The sample Pearson
product moment correlation coefficient r was applied to calculate the association between head
circumference z scores (negative values) and continuous variables obtained through the detailed
GMA (MOS and the number of movement or postural patterns). Sensitivity was calculated as
[a / (a + b)] and specificity as [d / (c + d)], where a indicates abnormal or absent fidgety movements
and adverse outcome (excluding microcephaly), b indicates normal fidgety movements and adverse
outcome (excluding microcephaly), c indicates abnormal or absent fidgety movements and normal
outcome, and d indicates normal fidgety movements and normal outcome.
Results
While all 333 control infants had normal fidgety movements, none of the 35 infants with
microcephaly developed this age-specific motor pattern. Among 76 infants in Rio de Janeiro without
microcephaly, 64 (84.2%) had normal fidgety movements, 3 (3.9%) had abnormal exaggerated
fidgety movements, and 9 (11.8%) did not show fidgety movements (Table 1). The rate of occurrence
of aberrant fidgety movements (ie, abnormal or absent) was 15.8% (12 of 76) in infants prenatally
exposed to acute maternal illness with rash but without microcephaly (9 infants of ZIKV-positive
mothers and 3 infants of ZIKV-negative mothers) (Table 2) and 100% (35 of 35) in infants with ZIKV-
induced microcephaly.
Infants prenatally exposed to acute maternal illness who did not develop microcephaly (Rio de
Janeiro cohort in the Figure) scored significantly lower on the MOS and all 5 subcategories compared
with neurotypical controls. Infants with microcephaly (Belo Horizonte cohort and 2 infants with
microcephaly from the Rio de Janeiro cohort) scored in the lowest range of the MOS and its 5
subscales (Table 1 and Table 3).
Maternal illness occurred in the first trimester of pregnancy (1-12 weeks) in 82.9% (29 of 35) of
infants diagnosed as having microcephaly compared with 28.9% (22 of 76) without microcephaly
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(P < .001) (Table 1). Aberrant fidgety movements in children without microcephaly exposed to
maternal illness were more frequent after first-trimester exposure (58.3% [7 of 12]) (P = .04). The
median MOS for infants exposed during the first trimester ranged from 21 (interquartile range [IQR],
11-26) to 24 (IQR, 20-26) when maternal illness occurred during the third trimester (P = .04). Five
of 10 ZIKV-exposed infants with adverse outcomes at age 12 months were born to mothers with an
acute illness and rash during the first trimester of pregnancy (cases 2, 5, 6, 7, and 9 in Table 4). Four
had no fidgety movements; their MOS was lower (range, 7-17). The ZIKV-positive mothers (n = 56)
had acute infection with rash more often in the first trimester of pregnancy than the ZIKV-negative
mothers (n = 20) (P = .03) (Table 2). However, the infants’ neuromotor repertoire at 3 to 5 months
was similar in infants of ZIKV-positive and ZIKV-negative mothers (Table 2).
Table 1. Clinical Characteristics and Motor Behavior at 3 to 5 Months’ Postterm Age
Variable
Infants Without
Microcephaly (n = 76)a
Infants With
Microcephaly (n = 35)b
Neurotypical
Controls (n = 333) P Valuec
Male, No. (%) 45 (59.2) 19 (54.3) 192 (57.7) NAd
Preterm birth, No. (%)
<34 wk gestation 2 (2.6) 0 6 (1.8)
NAd34-36 + 6 wk
gestation
8 (10.5) 5 (14.3) 39 (11.7)
Weeks of gestation at the
time of infection, wk,
No. (%)
≤13 22 (28.9) 29 (82.9) NA
<.001c,e14-28 42 (55.3) 6 (17.1) NA
≥29 12 (15.8) 0 NA
Age at GMA, wk, No. (%)
9-12 26 (34.2) 17 (48.6) 129 (38.7)
NAd13-16 44 (57.9) 14 (40.0) 174 (52.3)
17-20 6 (7.9) 4 (11.4) 30 (9.0)
Fidgety movements,
No. (%)f
Normal 64 (84.2) 0 333 (100)
NAAbnormal exaggerated 3 (3.9) 0 0













22 (28.9) 0 231 (69.4)
<.001e
Reduced ≤24, No. (%) 54 (71.1) 35 (100) 102 (30.6)
Repertoire, No. (%)
Age adequate 35 (46.1) 1 (2.9) 246 (73.9)
<.001e





Normal 3 (2-5) 0 (0-1) 5 (4-7) <.001g
Abnormal 1 (0-2) 4 (3-6) 0 (0-1) <.001g
Postural patterns,
median (IQR)
Normal 3 (2-3) 1 (1-1) 3 (3-4) <.001g
Abnormal 2 (1-3) 6 (5-8) 1 (0-2) <.001g
Movement character,
No. (%)h
Smooth and fluent 12 (15.8) 0 149 (44.7) <.001e
Stiff 22 (28.9) 33 (94.3) 59 (17.7) <.001e
Monotonous 38 (50.0) 34 (97.1) 89 (26.7) <.001e
Cramped-synchronizedi 0 19 (54.3) 0 NA
Abbreviations: GMA, general movement assessment;
IQR, interquartile range; NA, not applicable.
a Refers to 76 infants without microcephaly from the
Rio de Janeiro cohort who were prenatally exposed
to acute maternal illness with rash and whose
mothers were referred to Fundação Oswaldo Cruz
(Fiocruz) in Rio de Janeiro, Brazil. Prenatal and
perinatal data are reported elsewhere.2
b Refers to 33 infants from the Belo Horizonte cohort
plus 2 infants with microcephaly from the Rio de
Janeiro cohort.
c The statistics compare infants without microcephaly
vs infants with microcephaly.
d Matching criteria.
e Pearson χ2 test or Fisher exact test.
f Normal fidgety movements are small movements of
moderate speed with variable acceleration of the
neck, trunk, and limbs in all directions; abnormal
fidgety movements have a greater amplitude, speed,
and jerkiness. Whenever fidgety movements are
missing altogether from 9 to 20 weeks’ postterm
age, this abnormality is called absent fidgety
movements.9
g Mann-Whitney test.
h Because only the most frequently occurring
movement characters are listed here, the
percentages do not sum to 100%.
i A cramped-synchronized movement characteristic
denotes stiff movements; limb and trunk muscles
contract almost simultaneously and then relax
almost simultaneously.9
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There was no difference in gestational age at birth between infants exposed to acute maternal
illness with or without microcephaly (Table 1). Neither the presence of aberrant fidgety movements
nor the MOS was associated with preterm birth. However, both infants without microcephaly in the
Rio de Janeiro cohort born at less than 34 weeks’ gestation (Table 1) had adverse outcomes at age 12
months (cases 4 and 10 in Table 4).
Four infants were diagnosed as having moderate microcephaly (z score <−2); the remaining 31
infants had severe microcephaly (z score <−3). The MOS was not associated with head circumference
z scores (Pearson r = −0.048, P = .79). However, the more negative the z score was (ie, the smaller
the head circumference), the more abnormal were the movement patterns (Pearson r = 0.370,
P = .03). One patient developed secondary microcephaly (normocephalic at birth but with
subsequent postnatal microcephaly) with absent fidgety movements; the MOS was 8 (case 5 in
Table 4).
One infant with microcephaly due to congenital ZIKV infection died at 11 months. All 34 children
with congenital microcephaly had bilateral spastic cerebral palsy with Gross Motor Function
Classification System14 level V. They were unable to maintain antigravity head and trunk postures in
prone and sitting positions and required caregiver assistance to roll. Twenty-seven of 34 children
(79.4%) had epilepsy.
Table 2. Motor Behavior at 3 to 5 Months’ Postterm Age in the Rio de Janeiro Cohort (Excluding 2 Infants
With Microcephaly) by Maternal Positive vs Negative Real-time RT-PCR Assays
Variable
Positive for ZIKV by RT-PCR
Assay (n = 56)
Negative for ZIKV by RT-PCR
Assay (n = 20) P Value
Weeks of gestation at the time of infection,
wk, No. (%)
≤13 20 (35.7) 2 (10.0)
.03a14-28 26 (46.4) 16 (80.0)
≥29 10 (17.9) 2 (10.0)
Fidgety movements, No. (%)
Normal 47 (83.9) 17 (85.0)
.93aAbnormal exaggerated 2 (3.6) 1 (5.0)
Absent 7 (12.5) 2 (10.0)
Motor Optimality Score
Median (IQR) [range] 23 (18-26) [7-28] 23 (21-26) [7-27] .57b
Optimal range of 25-28, No. (%) 16 (28.6) 6 (30.0) .90a
Reduced ≤24, No. (%) 40 (71.4) 14 (70.0)
Abbreviations: IQR, interquartile range; RT-PCR,
reverse transcriptase–polymerase chain reaction; ZIKV,
Zika virus.
a Pearson χ2 test or Fisher exact test.
b Mann-Whitney test.





Microcephaly (n = 76)a
Infants With




Head not kept in midline 22 (28.9) 30 (85.7) 64 (19.2) .10
Asymmetric body posture 49 (64.5) 32 (91.4) 109 (32.7) <.001
Persistent asymmetric
tonic neck posture
0 9 (25.7) 0 NA
Hyperextension of neck
and/or trunk
0 26 (74.3) 1 (0.3) NA
Long-lasting extension of
arms
12 (15.8) 6 (17.1) 38 (11.4) .29
Long-lasting extension of
legs
9 (11.8) 32 (91.4) 26 (7.8) .26
External rotation and
abduction of hips
20 (26.3) 1 (2.9) 11 (3.3) <.001
Lack of variable finger
movements
26 (34.2) 35 (100) 77 (23.1) .08
Finger spreading 7 (9.2) 18 (51.4) 1 (0.3) <.001
Spreading of toes 0 18 (51.4) 0 NA
Abbreviation: NA, not applicable.
a Refers to 76 infants without microcephaly from the
Rio de Janeiro cohort who were prenatally exposed
to acute maternal illness with rash and whose
mothers were referred to Fundação Oswaldo Cruz
(Fiocruz) in Rio de Janeiro, Brazil. Prenatal and
perinatal data are reported elsewhere.2
b Refers to 33 infants from the Belo Horizonte cohort
plus 2 infants with microcephaly from the Rio de
Janeiro cohort.
c Infants without microcephaly vs neurotypical
controls (Pearson χ2 test or Fisher exact test).
JAMA Network Open | Pediatrics Prenatal Zika Virus Exposure and Clinical, Neurologic, and Developmental Status
JAMA Network Open. 2019;2(1):e187235. doi:10.1001/jamanetworkopen.2018.7235 (Reprinted) January 18, 2019 7/13
Downloaded From: https://jamanetwork.com/ by a Universitaet Augsburg User  on 04/28/2021
The neurodevelopmental outcomes of 56 children prenatally exposed to ZIKV without
congenital microcephaly were abnormal for 10 children (cases 1-10 in Table 4); 82.1% (46 of 56) of
ZIKV-exposed infants without congenital microcephaly were healthy at age 12 months. Forty-four of
46 infants (95.7%) whose development was considered normal at age 12 months (Bayley-III scores
within normal range or <1 SD in a single domain with normal neurologic findings) had normal fidgety
movements (P < .001) and were correctly identified by GMA at 3 months. Two children with
abnormal exaggerated fidgety movements were considered normal at age 12 months (cases 11 and 12
in Table 4). The negative predictive value was 94% (95% CI, 85%-97%). Seven of 10 ZIKV-exposed
children without microcephaly with adverse neurodevelopmental outcomes were identified by GMA.
Of 10 ZIKV-exposed children without microcephaly with an adverse outcome at age 12 months, 7
were identified by absent fidgety movements (cases 1-7 in Table 4). The remaining 3 had normal
fidgety movements (cases 8-10 in Table 4). The GMA positive predictive value was 78% (95% CI,
46%-94%). Sensitivity was 70% (95% CI, 35%-93%), and specificity was 96% (95% CI, 85%-99%).
Accuracy was 91% (95% CI, 80%-97%). The MOS also differentiated between normal and adverse
outcomes: children with normal outcomes whose mothers were ZIKV positive had a median MOS of
23 (IQR, 21-26), while children with an adverse outcome had a median MOS of 12 (IQR, 8-19)
(P = .001). The median MOS in children with microcephaly was 5 (IQR, 5-6).
Discussion
With the exception of a recent case report,15 our study is the first to perform a detailed functional
analysis of the developing nervous system in infants with prenatal ZIKV exposure. We aimed to
describe early motor functions and to search for potential markers of the neurodevelopmental
outcomes at age 12 months after ZIKV exposure. We observed that infants aged 3 to 5 months
prenatally exposed to ZIKV who did not develop congenital microcephaly moved less optimally
compared with neurotypical controls. The number of normal age-specific movement patterns was
Table 4. Brain Imaging, Fidgety Movements, and Motor Optimality Score, as Well as Outcome at Age 12 Months in Infants Exposed to ZIKV In Utero














Score Outcome at Age 12 mo




Absent 10 Bayley-III <2 SD (language), hyperreflexia and
hypertonia right > left
2 39 12 Normal Absent 7 Bayley-III <2 SD (motor)
3 37 18 Normal Absent 14 Bayley-III <1 SD (motor), dystonia,
neurodevelopmental delay by neurologic examination
4 31 30 Normal Absent 8 Bayley-III not available, neurologic and behavioral
deficits
5 39 10 Brain atrophy, calcifications Absent 8 Bayley-III not available, secondary microcephaly,
neurologically impaired, seizures
6 36 11 Hydrocephaly Absent 12 Bayley-III <1 SD (language), neurologically impaired
7 38 10 Normal Absent 11 Bayley-III <1 SD (cognition and language)
8 39 38 IVH grade 1 Normal 28 Bayley-III <2 SD (language)
9 39 6 Normal Normal 17 Bayley-III <2 SD (cognitive, language)
10 32 22 Periventricular
calcifications,
dolichocephaly
Normal 24 Bayley-III not available, macular hypoplasia,
neurodevelopmental delay, hypertonia of lower limbs
11 38 29 Normal Abnormal 14 Bayley-III <1 SD (language), neurologically normal
12a 37 12 Normal Abnormal 11 Bayley-III normal, neurologically normal
13-56 NA NA Normal (29 of 44),
abnormal (10 of 44),
not done (5 of 44)
Normal (44 of 44) 17-28 Bayley-III normal (29 of 44), Bayley-III <1 SD in a
single domain (10 of 44), Bayley-III not available
(5 of 44), neurologically normal (44 of 44)
Abbreviations: Bayley-III, Bayley Scales of Infant and Toddler Development, Third
Edition; IVH, intraventricular hemorrhage; NA, not applicable; ZIKV, Zika virus.
a Fetal development was compromised by oligohydramnios.
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reduced, and the quality of movements was altered (eAppendix in the Supplement). However, a
similar observation was made in 20 infants whose prenatal exposure to acute maternal illness with
rash could not be attributed to ZIKV and was possibly due to prenatal chikungunya exposure instead.
The results of some studies suggest that chikungunya virus may compromise the developing nervous
system in a similar but more subtle way.16
The most predictive movement patterns identified at 3 to 5 months’ postterm age are fidgety
general movements. Infants with normal, continual fidgety movements are likely to develop
neurotypically, whereas the lack of fidgety movements is a reliable marker for later neurologic
deficits, most extensively associated with cerebral palsy.8,10,11,17-19 Because all 35 children with
congenital microcephaly in the present study were diagnosed as having spastic cerebral palsy (Gross
Motor Function Classification System level V) at around age 1 year, the lack of fidgety movements in
this subgroup reflects the large body of evidence relating the absence of fidgety movements to
development of cerebral palsy. Microscopic neuropathological changes described in infants with
congenital microcephaly include necrosis-targeting neurons and degenerative changes of glia and
neuronal cells, white matter loss, microcalcifications, and microglial aggregates,20 which translate
into a lack of fidgety movements. Furthermore, we observed herein an association between head
circumference and neurofunctional representation: the smaller the head circumference was, the
more abnormal were the movement patterns noted. Apart from the absence of fidgety movements,
infants with microcephaly had few normal movement patterns.
There were 9 infants among 76 in the nonmicrocephalic cohort (11.8%) who did not develop
fidgety movements. Seven of them had confirmed prenatal exposure to ZIKV and an adverse
outcome at age 12 months (cases 1-7 in Table 4). In 4 cases, the absence of fidgety movements
identified infants at high risk of developing adverse outcomes, even with normal brain
imaging results.
It is well known that maternal infections, particularly early in pregnancy, are associated with
congenital microcephaly or other central nervous system abnormalities.20,21 Our study contributes
to the discussion on the timing of maternal ZIKV infection because absent fidgety movements
occurred more often when infants were exposed to maternal infection in the first trimester. Infants
with a lack of fidgety movements attracted our attention because of their long-lasting wiggling-
oscillating arm and/or leg movements, sometimes even wiggling neck movements, and occurring
repetitive and/or long-lasting tongue protrusion.
To date, few studies have demonstrated that neurologic development of infants with congenital
ZIKV infection can be abnormal in children without microcephaly.22,23 Cardoso and colleagues23
described neurologic signs in 19 infants born to mothers infected with ZIKV who did not develop
microcephaly; 13 (68.4%) were initially seen with hypertonia. We observed stiff movements in
one-third of the Rio de Janeiro cohort, including most infants with microcephaly. A stiff and/or
monotonous movement characteristic also occurred in neurotypical controls, although less
frequently. Ten-year outcomes of preterm infants demonstrated that children with monotonous,
jerky, and/or stiff movement at 3 to 5 months have reduced cognitive functioning at school age.24
Eighty-six percent of infants (96 of 111) in our cohort were born at term, so it is unknown if a less
optimal movement characteristic would be associated with school performance years later.
Apart from 333 neurotypical controls with normal fidgety movements at 3 to 5 months and a
Bayley-III score exceeding 85 at their follow-up assessment (100% specificity), normal fidgety
movements in the Rio de Janeiro cohort were associated with normal development at age 12 months,
with a specificity of 96%. Conversely, the absence of fidgety movements was associated with an
adverse outcome at age 12 months, with a sensitivity of 70%. Whereas the specificity coincides with
that of previous studies8,10,11 irrespective of the outcome assessment age, the sensitivity in the
present study is lower than the summary estimate (98%) for outcomes at 2 to 3 years10,11 but is in line
with other studies reporting outcome assessments at age 12 months. With sensitivity ranging from
60% to 80%, the absence of fidgety movements was similar to that in our study and was related to
lower scores in various developmental tests in a convenience high-risk sample in the United States,25
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among infants after neonatal surgery in Australia,26 and in very low-birth-weight infants in China27
and India,28 as well as to any pathological findings in the 12-month neurologic examination.19,29 We
acknowledge that an outcome at such a young age may be preliminary; some disorders might be
diagnosed later in childhood, and milder forms of dysfunction may subsequently resolve. The
predictive power of abnormal fidgety movements is known to be low,8,9 although a considerable
number of infants with abnormal fidgety movements were described among individuals prenatally
exposed to maternal opiate abuse and/or HIV who ultimately developed various
neurodevelopmental and psychiatric impairments.30
Considering that ZIKV is strongly neurotropic, targeting not only neural progenitor cells but also
neurons and other brain cells,20 our proportion of infants with normal fidgety movements at 3 to 5
months and normal neurodevelopment at age 12 months (78.6% [44 of 56]) was reassuring. We
confirmed that GMA provides an opportunity to identify children with normal development. The high
specificity of GMA is useful because it may help limit unnecessary referral of infants to heavily
burdened rehabilitation services, especially in low- and middle-income countries. Implementing
GMA may also facilitate prompt referral to such services, which can optimize development, prevent
secondary complications, and enhance family well-being. In this context, we emphasize that GMA is
easy to apply and is a cost-effective method, especially for low- and middle-income countries.9,28
Limitations
Given the study complexity, there were limitations related to data availability. For our comprehensive
assessment of endogenously generated motor behavior during the first months of life, we assessed
44.8% (56 of 125) of the original Zika Rio de Janeiro cohort.2 The main reason for the reduced sample
size is that infants were followed up at different sites throughout Rio de Janeiro, which reduced
patient availability for GMA assessments. In addition, GMA evaluations were performed at strict
intervals, and often infants were either too young or too old within the time frame for this
assessment. Another study limitation is that many mothers with negative ZIKV RT-PCR results opted
not to continue long-term developmental follow-up of their infants. For this reason, Bayley-III
assessments were not available for infants of ZIKV-negative mothers.
Conclusions
Our study provides insight into the spectrum of both neurologic sequelae and normal outcomes
observed from age 3 to 12 months in children prenatally exposed to maternal ZIKV infection. Most
ZIKV-exposed children without microcephaly (82.1% [46 of 56]) were classified as healthy at age 12
months. Because the true rate of transmission of ZIKV from mother to child is unknown, the
association of GMA with sequelae due to ZIKV could actually be superior to the results reported
herein if the population of infants evaluated was composed solely of infected infants rather than
exposed. Further investigation of long-term sequelae in ZIKV-exposed infants, such as late
presenting developmental disorders, is required. Our findings demonstrate that children with
adverse outcomes can be reliably identified by GMA, which is a valid complementary assessment
tool. We recommend its incorporation for routine assessment of infants prenatally exposed to acute
maternal illnesses. General movement assessment will help identify infants who may benefit from
targeted intervention programs.
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